Canada approves Bayer's riociguat for CTEPH

Health Canada approved Adempas riociguat from Bayer AG (Xetra:BAYN) to treat inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after surgery in pulmonary hyperte...